This white paper presents six significant quality and compliance oversights that pharmaceutical companies may unknowingly propagate or encourage over time.
At a corporate level, quality and compliance management in heavily regulated pharmaceutical environments is a tricky endeavor. After all, success in the areas of quality and compliance can only be achieved when a multitude of variables are controlled and continually maintained. This white paper will discuss how to improve upon:
Investment in CROs
Training for Corporate Personnel
Investment in Successful Technologies
Understanding and/or Investment in Pharmacovigilance and Pharmacoepidemiology
Understanding or Investment in Risk-Based Management